돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 3501생성일: 2026년 10월 23일

Chlorosuccinimide → N-[4-(3-Chloro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)ylcarbonyl)phenyl]-2-methylbenzamide

https://huagongshe.com/ko/reaction/3501

반응식

참여 물질

역할이름HCID투입량
반응물ChlorosuccinimideHCID 31398—
반응물2-Methyl-N-[4-(5H-pyrrolo[2,1-c][1,4]-benzodiazepin-10(11H)-ylcarbonyl)phenyl]benzamideHCID 10764664—
용매TetrahydrofuranHCID 8028—
생성물N-[4-(3-Chloro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)ylcarbonyl)phenyl]-2-methylbenzamideHCID 2183698368.8%

반응 단계

To an ice-water cooled suspension of 211 mg of 2-methyl-N-[4-(5H-pyrrolo[2,1-c][1,4]-benzodiazepin-10(11H)-ylcarbonyl)-phenyl]benzamide in 5 ml of tetrahydrofuran is added 67 mg of N-chlorosuccinimide followed by continued stirring in the cold for 10 minutes. The bath is removed and stirring continued for 2.25 hours. The reaction mixture is added to ice-water and extracted with ether. The organic layer is dried and concentrated in vacuo to give a foam which is crystallized from ethyl acetate-hexane to give 157 mg of the desired product as an orange-pink solid, m.p. 185°-187° C.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05733905
출처 데이터셋uspto-grants-1998_03
ORD IDord-541e4ed91a3e4fd299ddfcb9db583d18
출처 메모uspto-grants-1998_03